PatientsVille.com Logo

PatientsVille

Valcote Side Effects

Common Valcote Side Effects


The most commonly reported Valcote side effects (click to view or check a box to report):

Dysarthria (3)
Testis Cancer (3)
Syncope (3)
Hyperammonaemia (3)
Convulsion (3)
Sensory Disturbance (3)
Loss Of Consciousness (3)
Salivary Hypersecretion (3)
Ataxia (2)
Confusional State (2)
Vomiting (2)
Aphasia (2)
Disorientation (2)
Psychotic Disorder (2)
Ventricular Extrasystoles (2)
Encephalopathy (2)
Presyncope (2)
Myopia (2)
Suicide Attempt (1)
Accidental Overdose (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Valcote Side Effects Reported to FDA

The following Valcote reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Valcote on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Cerebral Ischaemia, Aortic Dissection
This is a report of a 51-year-old male patient (weight: NA) from CO, suffering from the following symptoms/conditions: epilepsy, who was treated with Valcote (dosage: NA, start time: Oct 10, 2012), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Cerebral Ischaemia
  • Aortic Dissection
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Valcote treatment in male patients, resulting in cerebral ischaemia side effect. The patient was hospitalized.

Accidental Overdose, Somnolence
This report suggests a potential Valcote Accidental Overdose, Somnolence side effect(s) that can have serious consequences. A 16-year-old male patient (weight: NA) from AR was diagnosed with the following symptoms/conditions: schizophrenia and used Valcote (dosage: 2, 0000 Mg) starting Oct 11, 2011. Soon after starting Valcote the patient began experiencing various side effects, including:
  • Accidental Overdose
  • Somnolence
Drugs used concurrently:
  • Clozapine
Although Valcote demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as accidental overdose, may still occur.

Convulsion, Stevens-johnson Syndrome
This Convulsion, Stevens-johnson Syndrome problem was reported by a physician from VENEZUELA. A 69-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: depression,convulsion. On May 01, 2010 this consumer started treatment with Valcote R (dosage: 1500 Mg Daily). The following drugs were being taken at the same time:
  • Lamictal (75 Mg Daily)
When commencing Valcote R, the patient experienced the following unwanted symptoms/side effects:
  • Convulsion
  • Stevens-johnson Syndrome
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as convulsion, may become evident only after a product is in use by the general population.

Ataxia, Confusional State, Disorientation, Dysarthria, Encephalopathy, Psychotic Disorder
This is a report of a 42-year-old female patient (weight: NA) from CHILE. The patient developed the following symptoms/conditions: bipolar disorder,mania,bipolar i disorder and was treated with Valcote Tablets (dosage: NA) starting Oct 26, 2009. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Ataxia
  • Confusional State
  • Disorientation
  • Dysarthria
  • Encephalopathy
  • Psychotic Disorder
The patient was hospitalized. This opens a possibility that Valcote Tablets treatment could cause the above reactions, including ataxia, and some female subjects may be more susceptible.


Ataxia, Confusional State, Disorientation, Dysarthria, Encephalopathy, Psychotic Disorder
A 42-year-old female patient (weight: NA) from CHILE with the following symptoms/conditions: bipolar disorder,mania started Valcote Tablets treatment (dosage: NA) on Oct 26, 2009. Soon after starting Valcote Tablets treatment, the subject experienced various side effects, including:
  • Ataxia
  • Confusional State
  • Disorientation
  • Dysarthria
  • Encephalopathy
  • Psychotic Disorder
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Valcote Tablets.

Myopia
A 18-year-old female patient from ARGENTINA (weight: NA) experienced symptoms, such as: impulsive behaviour and was treated with Valcote(dosage: NA). The treatment was initiated on Dec 01, 2007. After that a consumer reported the following side effect(s):
  • Myopia
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Valcote efficacy: NA.

Intestinal Cyst
In this report, Valcote Tablets was administered for the following condition: NA.A 47-year-old consumer from ARGENTINA (weight: NA) started Valcote Tablets treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Intestinal Cyst
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Valcote Tablets treatment could be related to the listed above side effect(s).

Corneal Deposits, Myopia
This is a report of the following Valcote side effect(s):
  • Corneal Deposits
  • Myopia
A 18-year-old female patient from ARGENTINA (weight: NA) presented with the following condition: impulsive behaviour and received a treatment with Valcote (dosage: NA) starting: Dec 01, 2007.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Valcote treatment could be associated with the listed above side effect(s).

Presyncope
This Valcote Er report was submitted by a female consumer from FRANCE (weight: NA). The patient was diagnosed with: bipolar disorder and Valcote Er was administered (dosage: NA) starting: Jan 01, 2007. The consumer developed a set of symptoms:
  • Presyncope
Other drugs used simultaneously:
  • Olanzapine
The patient was hospitalized.Those unexpected symptoms could be linked to a Valcote Er treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Convulsion
This is a report of a possible correlation between Valcote Tablets use and the following symptoms/side effect(s):
  • Convulsion
which could contribute to an assessment of Valcote Tablets risk profile.A 25-year-old consumer from ARGENTINA (weight: NA) was suffering from NA and was treated with Valcote Tablets (dosage: NA) starting Dec 01, 2008.Other concurrent medications: NA.

Overdose, Suicide Attempt
A 39-year-old male patient from ARGENTINA (weight: NA) presented with the following symptoms: NA and after a treatment with Valcote Tablets (dosage: NA) experienced the following side effect(s):
  • Overdose
  • Suicide Attempt
The treatment was started on Jan 01, 2008. Valcote Tablets was used in combination with the following drugs:
  • Clonazepam
  • Lithium Carbonate
  • Lamotrigine
The patient was hospitalized.This report could alert potential Valcote Tablets consumers.

Fatigue, Immunosuppression, Organ Failure, Pyrexia, Salivary Hypersecretion, Testis Cancer, Weight Decreased
In this report, a male patient from ARGENTINA (weight: NA) was affected by a possible Valcote Tablets side effect.The patient was diagnosed with borderline personality disorder. After a treatment with Valcote Tablets (dosage: NA, start date: Jan 01, 2008), the patient experienced the following side effect(s):
  • Fatigue
  • Immunosuppression
  • Organ Failure
  • Pyrexia
  • Salivary Hypersecretion
  • Testis Cancer
  • Weight Decreased
The following simultaneously used drugs could have led to this reaction:
  • Clozapine
  • Clonazepam
  • Risperidone
The findings here stress that side effects should be taken into consideration when evaluating a Valcote Tablets treatment.

Salivary Hypersecretion, Testis Cancer
This is a report of a male patient from ARGENTINA (weight: NA), who used Valcote Tablets (dosage: NA) for a treatment of borderline personality disorder. After starting a treatment on Jan 01, 2008, the patient experienced the following side effect(s):
  • Salivary Hypersecretion
  • Testis Cancer
The following drugs could possibly have interacted with the Valcote Tablets treatment
  • Clozapine
  • Clonazepam
  • Risperidone
Taken together, these observations suggest that a Valcote Tablets treatment could be related to side effect(s), such as Salivary Hypersecretion, Testis Cancer.

Salivary Hypersecretion, Testis Cancer
This salivary hypersecretion side effect was reported by a consumer or non-health professional from ARGENTINA. A male patient (weight:NA) experienced the following symptoms/conditions: borderline personality disorder. The patient was prescribed Valcote Tablets (dosage: NA), which was started on Jan 01, 2008. Concurrently used drugs:
  • Clozapine
  • Risperidone
When starting to take Valcote Tablets the consumer reported the following symptoms:
  • Salivary Hypersecretion
  • Testis Cancer
These side effects may potentially be related to Valcote Tablets.

Presyncope
This is a Valcote Er side effect report of a female patient (weight:NA) from FRANCE, suffering from the following symptoms/conditions: bipolar disorder, who was treated with Valcote Er (dosage:NA, start time: Jan 01, 2007), combined with:
  • Olanzapine
, and developed a serious reaction and a presyncope side effect. The patient presented with:
  • Presyncope
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Valcote Er treatment in female patients suffering from bipolar disorder, resulting in presyncope.

Syncope
This report suggests a potential Valcote Er syncope side effect(s) that can have serious consequences. A female patient from ARGENTINA (weight:NA) was diagnosed with the following health condition(s): bipolar disorder and used Valcote Er (dosage: NA) starting Jan 01, 2007. Soon after starting Valcote Er the patient began experiencing various side effects, including:
  • Syncope
Drugs used concurrently:
  • Olanzapine
The patient was hospitalized. Although Valcote Er demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as syncope, may still occur.

Depressed Level Of Consciousness, Dysarthria, Motor Dysfunction, Psychomotor Hyperactivity
This depressed level of consciousness problem was reported by a physician from CHILE. A 25-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): bipolar disorder,depression.On Jul 15, 2008 a consumer started treatment with Valcote Er (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Valcote Er, the patient experienced the following unwanted symptoms /side effects:
  • Depressed Level Of Consciousness
  • Dysarthria
  • Motor Dysfunction
  • Psychomotor Hyperactivity
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as depressed level of consciousness, may become evident only after a product is in use by the general population.

Convulsion
This is a Valcote side effect report of a female patient (weight: NA) from ARGENTINA. The patient developed the following symptoms/conditions: cytogenetic abnormality,insomnia and was treated with Valcote (dosage: 250 Mg (8 Am) 500mg (2 Pm)) starting Jan 01, 2007. Concurrently used drugs:
  • Melatonin
Soon after that, the consumer experienced the following of symptoms:
  • Convulsion
This opens a possibility that Valcote could cause convulsion and that some female patients may be more susceptible.

Aphasia, Hyperammonaemia, Loss Of Consciousness, Sensory Disturbance, Vomiting
A 50-year-old female patient (weight: NA) from ARGENTINA with the following symptoms: mania,bipolar disorder started Valcote treatment (dosage: NA) on Jul 27, 2005. Soon after starting Valcote treatment, the consumer experienced several side effects, including:
  • Aphasia
  • Hyperammonaemia
  • Loss Of Consciousness
  • Sensory Disturbance
  • Vomiting
. Concurrently used drugs:
  • Clonazepam
  • Fluoxetine (6/25 Mg)
  • Flumazenil
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Valcote side effects, such as aphasia.

Ventricular Extrasystoles
This ventricular extrasystoles side effect was reported by a physician from ARGENTINA. A 68-year-old female patient (weight:NA) experienced the following symptoms/conditions: bipolar disorder.The patient was prescribed Valcote (dosage: NA), which was started on Jan 15, 2007. Concurrently used drugs: NA..When starting to take Valcote the consumer reported symptoms, such as:
  • Ventricular Extrasystoles
These side effects may potentially be related to Valcote.

Ventricular Extrasystoles
This is a report of a 68-year-old female patient (weight: NA) from ARGENTINA, suffering from the following symptoms/conditions: bipolar disorder, who was treated with Valcote (dosage: NA, start time: Jan 15, 2007), combined with:
  • Risperidone
and developed a serious reaction and side effect(s). The consumer presented with:
  • Ventricular Extrasystoles
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Valcote treatment in female patients, resulting in ventricular extrasystoles side effect.

Amnesia, Hemianopia, Visual Acuity Reduced
This report suggests a potential Valcote Er Amnesia, Hemianopia, Visual Acuity Reduced side effect(s) that can have serious consequences. A 35-year-old male patient (weight: NA) from VENEZUELA was diagnosed with the following symptoms/conditions: major depression,hypertension and used Valcote Er (dosage: NA) starting May 01, 2005. Soon after starting Valcote Er the patient began experiencing various side effects, including:
  • Amnesia
  • Hemianopia
  • Visual Acuity Reduced
Drugs used concurrently:
  • Propranolol
  • Nimodipine
  • Lexapro
Although Valcote Er demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as amnesia, may still occur.

Aphasia, Hyperammonaemia, Loss Of Consciousness, Sensory Disturbance, Vomiting
This Aphasia, Hyperammonaemia, Loss Of Consciousness, Sensory Disturbance, Vomiting problem was reported by a consumer or non-health professional from ARGENTINA. A 50-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: mania,bipolar disorder. On Jul 27, 2005 this consumer started treatment with Valcote (dosage: NA). The following drugs were being taken at the same time:
  • Clonazepam
  • Fluoxetine (6/25 Mg)
  • Flumazenil
When commencing Valcote, the patient experienced the following unwanted symptoms/side effects:
  • Aphasia
  • Hyperammonaemia
  • Loss Of Consciousness
  • Sensory Disturbance
  • Vomiting
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as aphasia, may become evident only after a product is in use by the general population.

Hyperammonaemia, Loss Of Consciousness, Sensory Disturbance
This is a report of a 50-year-old female patient (weight: NA) from ARGENTINA. The patient developed the following symptoms/conditions: mania,bipolar disorder and was treated with Valcote (dosage: NA) starting Jul 20, 2005. Concurrently used drugs:
  • Clonazepam
  • Fluoxetine
Soon after that, the consumer experienced the following side effects:
  • Hyperammonaemia
  • Loss Of Consciousness
  • Sensory Disturbance
The patient was hospitalized. This opens a possibility that Valcote treatment could cause the above reactions, including hyperammonaemia, and some female subjects may be more susceptible.

Completed Suicide
A 28-year-old male patient (weight: NA) from with the following symptoms/conditions: bipolar disorder started Valcote Tablets treatment (dosage: NA) on Feb 21, 2005. Soon after starting Valcote Tablets treatment, the subject experienced various side effects, including:
  • Completed Suicide
Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Valcote Tablets.



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Valcote Side Effects

    Did You Have a Valcote Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Valcote for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Valcote Safety Alerts, Active Ingredients, Usage Information

    More About Valcote

    Side Effects reported to FDA: 25

    Valcote safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 5

    Latest Valcote clinical trials

    Valcote Reviews

    No reviews, be a first to report a side effect via side effect reporting form